Last quarter (Q4 2023), Molecular Partners AG's total revenue was CHF―, a decrease of -100.00% from the same quarter last year. In Q4, Molecular Partners AG's net income was CHF―. See Molecular Partners AG’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	CHF 14.09M	CHF 7.04M	CHF 189.60M	CHF 9.75M	CHF 9.34M	CHF 20.38M
Cost of Revenue	-	-	CHF -72.99M	CHF -73.17M	-	-
Gross Profit	-	CHF 7.04M	CHF 189.54M	CHF 9.33M	-	-
Operating Expense	CHF 35.07M	CHF 67.29M	CHF 73.61M	CHF 73.17M	CHF 67.67M	CHF 57.04M
Operating Income	CHF -20.99M	CHF -60.26M	CHF 115.93M	CHF -63.84M	CHF -58.33M	CHF -36.66M
Net Non Operating Interest Income Expense	CHF 53.00K	CHF 4.23M	CHF 1.86M	CHF 191.00K	CHF 63.00K	CHF 1.50M
Other Income Expense	CHF 3.09M	CHF 853.00K	CHF -5.38M	CHF -424.00K	CHF -4.51M	CHF -1.11M
Pretax Income	CHF -17.84M	CHF -61.98M	CHF 117.85M	CHF -63.78M	CHF -62.77M	CHF -36.27M
Tax Provision	-	-	-	CHF 2.00K	CHF -11.00K	CHF 17.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	CHF -17.84M	CHF -61.98M	CHF 123.17M	CHF -55.78M	CHF -62.76M	CHF -36.29M
Basic EPS	CHF -0.56	CHF -1.89	CHF 3.63	CHF -2.06	CHF -2.51	CHF -1.69
Diluted EPS	CHF -0.56	CHF -1.89	CHF 3.54	CHF -2.06	CHF -2.51	CHF -1.69
Basic Average Shares	CHF 65.02M	CHF 32.77M	CHF 32.47M	CHF 31.01M	CHF 25.00M	CHF 21.41M
Diluted Average Shares	CHF 65.73M	CHF 32.77M	CHF 34.79M	-	CHF 25.00M	CHF 21.41M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	CHF 35.07M	CHF 67.29M	CHF 619.00K	-	CHF 67.67M	CHF 57.04M
Net Income From Continuing And Discontinued Operation	CHF -17.84M	CHF -61.98M	CHF 123.17M	CHF -55.78M	CHF -62.76M	CHF -36.29M
Normalized Income	CHF -20.93M	-	-	-	CHF -58.25M	CHF -35.38M
Interest Expense	CHF 350.00K	-	-	-	CHF 295.00K	CHF 64.00K
EBIT	CHF -17.49M	-	CHF 117.85M	CHF -63.78M	CHF -62.48M	CHF -36.21M
EBITDA	CHF -16.33M	-	CHF 120.24M	CHF -61.22M	CHF -59.59M	CHF -33.74M

Currency in CHF

Molecular Partners AG Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing